Scarica l'app Stockscreener
247.26
1.61%
-4.05
Dopo l'orario di chiusura:
247.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KRYS Giù?
Forum
Previsione
Krystal Biotech Inc Borsa (KRYS) Ultime notizie
Krystal Biotech Stock Surges on Q4 Beat, But Valuation Questions Linger After CEO Share Sale - AD HOC NEWS
Assessing Krystal Biotech (KRYS) Valuation After Q4 2025 Beat And CEO Stock Sale - simplywall.st
First Trust Advisors LP Has $43.85 Million Stake in Krystal Biotech, Inc. $KRYS - MarketBeat
Capital World Investors Cuts Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025 - AOL.com
8,212 Shares in Krystal Biotech, Inc. $KRYS Bought by WINTON GROUP Ltd - MarketBeat
The Bull Case For Krystal Biotech (KRYS) Could Change Following Q4 Beat And CEO Stock Sales - Sahm
(KRYS) Risk Channels and Responsive Allocation - Stock Traders Daily
Krystal Biotech, Inc. $KRYS Position Trimmed by GW&K Investment Management LLC - MarketBeat
Krishnan Krish S, president of Krystal Biotech, sells $6.58 million in KRYS stock - Investing.com Canada
Krystal Biotech (NASDAQ:KRYS) Insider Sells $6,580,250.00 in Stock - MarketBeat
Krystal Biotech director Krishnan sells $6.58 million in shares By Investing.com - Investing.com South Africa
Krystal Biotech director Krishnan sells $6.58 million in shares - Investing.com
Krystal Biotech (KRYS) R&D president sells 25,000 shares under 10b5-1 plan - Stock Titan
[144] Krystal Biotech, Inc. SEC Filing - Stock Titan
Segall Bryant & Hamill LLC Lowers Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Krystal Biotech at TD Cowen Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Kathryn Romano Sells 750 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Daniel Janney Sells 11,803 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million By Investing.com - Investing.com Canada
Daniel Janney sells Krystal Biotech (KRYS) shares worth $3.25 million - Investing.com
Krystal Biotech (KRYS) CAO sells shares and receives fresh stock awards - Stock Titan
Krystal Biotech (KRYS) R&D chief logs new awards, PSU vesting and tax trades - Stock Titan
Krystal Biotech (NASDAQ: KRYS) CEO reports new equity awards and tax share surrenders - Stock Titan
Alta Bioequities linked to Krystal Biotech (KRYS) director sells 11,803 shares - Stock Titan
Krystal Biotech, Inc. $KRYS Position Increased by William Blair Investment Management LLC - MarketBeat
TD Asset Management Boosts Stake in Krystal Biotech - National Today
TD Asset Management Inc Boosts Position in Krystal Biotech, Inc. $KRYS - MarketBeat
KRYS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Kathryn Romano sells 12,500 KRYS shares (NASDAQ: KRYS); 750 more vest - Stock Titan
Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising Genetic Medicine Leader with 13.63% Potential Upside - DirectorsTalk Interviews
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Krystal Biotech (KRYS) Is Up 5.6% After Stronger 2025 Profitability And EPS Growth Has The Bull Case Changed? - Sahm
Guggenheim Lifts PT on Krystal Biotech (KRYS) to $284 From $224 - Yahoo Finance
Krystal Biotech director Janney sells shares worth $10.1 million - Investing.com
Krystal Biotech director Janney sells shares worth $10.1 million By Investing.com - Investing.com South Africa
Krystal Biotech (NASDAQ:KRYS) Director Daniel Janney Sells 700 Shares - MarketBeat
Krystal Biotech (NASDAQ:KRYS) Director Daniel Janney Sells 37,895 Shares - MarketBeat
Daniel Janney Sells 7,741 Shares of Krystal Biotech (NASDAQ:KRYS) Stock - MarketBeat
Krystal Biotech Director Janney Daniel Sells Over $16 Million in Company Stock - TradingView
Vanguard Group Inc. Cuts Stock Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Assessing Krystal Biotech (KRYS) Valuation After Earnings Beat And Profitability Milestone - simplywall.st
(KRYS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Krystal Biotech (NASDAQ:KRYS) Given New $284.00 Price Target at Guggenheim - MarketBeat
Guggenheim Raises Price Target for Krystal Biotech (KRYS) to $28 - GuruFocus
Krystal Biotech slips more than 2% even after Q4 earnings and revenue top estimates - MSN
Risk On: Can Krystal Biotech Inc weather a recessionJuly 2025 Market Mood & Growth Focused Entry Reports - baoquankhu1.vn
Insider Unloading: Dino A Rossi Sells Options, Realizes $5.04M - Benzinga
Krystal Biotech to Present at TD Cowen 46th Annual Health Care Conference - Bitget
Krystal Biotech execs to host TD Cowen fireside chat March 3 - Stock Titan
Krystal Biotech’s KB707 RMAT Win Opens New Lung Cancer Chapter - Yahoo Finance
Krystal Biotech Insider Sold Shares Worth $4,953,694, According to a Recent SEC Filing - marketscreener.com
Krystal Biotech (NASDAQ:KRYS) Director Sells $4,953,719.50 in Stock - MarketBeat
Krystal Biotech (KRYS) director Rossi sells shares worth $4.95 million - Investing.com
Krystal Biotech (KRYS) director Rossi sells shares worth $4.95 million By Investing.com - Investing.com India
Krystal Biotech Director Dino A. Rossi Sells Shares - TradingView
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):